Top Buy Stocks
Sign In
Invest in GILD
$102.50
+2.16 (+2.15%)
At Close: May 16, 2025
2 Dividend Stocks That are Holding Their Own in 2025
11:56am, Saturday, 17'th May 2025
Perhaps it's not all too surprising to witness the S&P 500 run into turbulence after two of the best years for stock gains in recent memory.
FOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society
Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?
10:01am, Thursday, 15'th May 2025
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
Gilead Sciences, Inc. (GILD) BofA Securities Health Care Conference Transcript
07:32pm, Tuesday, 13'th May 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) BofA Securities Health Care Conference May 13, 2025 2:20 PM ET Company Participants Johanna Mercier – Chief Commercial Officer Conference Call Participants Tim A
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
12:30pm, Monday, 12'th May 2025
President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up t
2 High-Yield Dividend Stocks to Buy in May and Hold Forever
08:45am, Saturday, 10'th May 2025
When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but the most critical factor to consider is a company's underlying operations.
Pressure is still on the pharma sector, says Mizuho's Jared Holz
07:23pm, Thursday, 08'th May 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
Gilead announces $11 billion in new investments in US
02:52pm, Wednesday, 07'th May 2025
Gilead Sciences on Wednesday announced $11 billion in capital and operational investments in the U.S. to supplement an already planned spending of $21 billion in domestic manufacturing and R&D through
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences Inc. (Nasdaq: GILD) today announced final results from the pivotal Phase 3 MYR301 study revealing that 36% (23 out of 64) of adults living with ch
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the Euro
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
10:46am, Monday, 05'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
07:02am, Friday, 02'nd May 2025
In today's unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those
Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss?
10:10am, Wednesday, 30'th Apr 2025
GILD is trading down after disappointing first-quarter results. While the fundamentals look solid in the long run, the oncology business is under pressure.
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
10:06am, Wednesday, 30'th Apr 2025
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
